NCT05912192

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 163 (actual)
• Sponsor: National University of Malaysia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis. There are two hypotheses of this study: 1. Elonide nasal spray is same efficacy to Nasonex nasal spray. 2. Elonide nasal spray is more efficient to placebo.

Detailed description

There are several objectives of the study: 1. To compare the efficacy of Elonide to Nasonex and Placebo in treating allergic rhinitis via Quality of life assessments and nasal airflow improvements. 2. To compare the efficacy of Elonide to Nasonex and Placebo in treating allergic rhinitis via symptomatics improvement. 3. To assess the side effect of Nasal spray given. Patients who meet the criteria to join the study will be randomized in a double-blind manner (patients and investigators). Patients will be given information about the study and consent form, patients will be randomized to 3 treatment group(Elonide, Nasonex, Placebo). Patients will be evaluated before and after treatment in one month time. Patients will be advised to use the nasal spray twice daily.

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Elonide Nasal Spray	50mcg/dose One puff for each nostrils twice daily
DRUG	Nasonex Nasal Spray	50mcg/dose One puff for each nostrils twice daily
DRUG	Normal saline	50mcg/dose of 0.9% sodium chloride One puff for each nostrils twice daily

Timeline

• Start date: 2022-02-24
• Primary completion: 2023-04-14
• Completion: 2023-04-14
• First posted: 2023-06-22
• Last updated: 2023-06-22

Locations

1 site across 1 country: Malaysia